StockData

Zhengye Biotechnology Holding Ltd (ZYBT) stock

ZYBTNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.52+0.09 (+6.29%)

Close on Nov 17, 2026Market cap $72.03MP/E –Yield –

Zhengye Biotechnology EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Zhengye Biotechnology's EV/EBITDA was 7.9× on Feb 27, 2026, against 22.3× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 20267.9×−3.6
2025Dec 31, 202511.5×–

More Zhengye Biotechnology figures

See a number that looks wrong?